POPULARITY
Categories
202 episodes with Phase
486 episodes with Phase
100 episodes with Phase
92 episodes with Phase
126 episodes with Phase
65 episodes with Phase
51 episodes with Phase
116 episodes with Phase
43 episodes with Phase
56 episodes with Phase
51 episodes with Phase
29 episodes with Phase
55 episodes with Phase
45 episodes with Phase
47 episodes with Phase
35 episodes with Phase
86 episodes with Phase
45 episodes with Phase
41 episodes with Phase
33 episodes with Phase
45 episodes with Phase
44 episodes with Phase
73 episodes with Phase
46 episodes with Phase
30 episodes with Phase
15 episodes with Phase
33 episodes with Phase
41 episodes with Phase
61 episodes with Phase
30 episodes with Phase
33 episodes with Phase
20 episodes with Phase
27 episodes with Phase
62 episodes with Phase
45 episodes with Phase
43 episodes with Phase
58 episodes with Phase
30 episodes with Phase
32 episodes with Phase
19 episodes with Phase
12 episodes with Phase
49 episodes with Phase
26 episodes with Phase
490 episodes with Phase
30 episodes with Phase
23 episodes with Phase
18 episodes with Phase
31 episodes with Phase
42 episodes with Phase
28 episodes with Phase
39 episodes with Phase
17 episodes with Phase
23 episodes with Phase
51 episodes with Phase
On today's HighWire, Former CDC Director Robert Redfield is now saying the quiet part out loud, admitting we were right about mRNA and spike protein. Also, Del Celebrates RFK Jr.'s Announcement of 21 new members of the Interagency Autism Coordinating Committee (IACC), the committee responsible for coordinating the government's autism research and response. This is huge, and Del has the details.Then, we examine Moderna's announcement that it is halting new Phase 3 vaccine trials, citing reduced market incentives under increased federal oversight. What does this decision reveal about safety testing, accountability, and public health priorities?Also, a deep dive into the UK's newly announced AI surveillance system — described by officials as a “panopticon.” We unpack the origins of the term and what it signals about the future of mass surveillance.Plus, as fraud investigations rock Minnesota, autism education providers are facing devastating funding cuts. Jennifer Larson of Holland Center joins Del to explain how legitimate, long-standing programs are now at risk — and how families are paying the price.Guest: Jennifer LarsonBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Most detox advice online is wrong — and can actually make you feel worse. In this episode, we break down how true liver detoxification really works through Phase 1 activation, Phase 2 processing, and Phase 3 elimination. You'll learn why detox symptoms happen, why constipation blocks detox pathways, and how issues like histamine intolerance, estrogen dominance, migraines, and chemical sensitivity connect to specific detox routes like methylation, sulfation, and glucuronidation. We also explain why throwing NAC, B vitamins, and “detox supplements” at your body without proper elimination support can backfire — and what to support first instead. *** CONNECT:
Broadcast from KSQD, Santa Cruz on 1-29-2026: An emailer asks about hemorrhoids affecting 2 relatives,a 60-year-old man and his 20-year-old daughter, with the daughter also experiencing constipation worsened by fiber supplements. Dr. Dawn explains hemorrhoids are essentially varicose veins of the anus, with 102 genetic regions identified affecting blood vessel and smooth muscle strength. She emphasizes that fiber supplements without adequate water create "cement in the pipe"—recommending 16-24 ounces of water with supplements and 2 liters of clear water daily. Miralax also requires sufficient hydration to work. Key strategies include exercise to stimulate gut motility, staying off the toilet if unable to produce results, using a standing desk to reduce prolonged sitting pressure, and triggering the gastrocolic reflex by eating. Dr. Dawn discusses research on the "volatilome"—volatile organic compounds in breath that reflect gut microbiome composition. Researchers using sterile mice colonized with specific bacteria could identify bacterial fingerprints through breath analysis. The technique identified disease-associated compounds for tuberculosis and malaria, and correlated specific gut bacteria with asthma severity in children. The research suggests breath testing could eventually replace stool samples for microbiome assessment and disease screening. She explains detoxification biochemistry, distinguishing between water-soluble toxins easily filtered by kidneys and fat-soluble toxins requiring liver transformation. Phase one converts fat-soluble molecules into reactive intermediates—dangerous if they linger—while phase two attaches water-soluble molecules like glutathione to neutralize them for excretion. Supporting phase two requires green tea, cruciferous vegetables, garlic, and curcumin. She cautions against extended fasting for detox, especially over age 50, as it depletes the body's detoxification resources and muscle mass. A caller asks about alkaline versus acidic water. Dr. Dawn explains you cannot alkalinize blood since kidneys maintain pH, but alkaline urine is beneficial. Rather than expensive alkaline waters, adding a pinch of baking soda achieves the same effect. Eating a 3:1 ratio of fruits, vegetables, and grains to animal products naturally alkalinizes urine. She notes lemons paradoxically alkalinize because kidneys overcompensate for the acid load. A caller asks about managing heart disease after receiving a third stent. Dr. Dawn recommends the Mediterranean diet over DASH for cardiac patients, as Mediterranean emphasizes fish, whole grains, and fiber that binds cholesterol for excretion, while DASH focuses on calcium for hypertension. She encourages exploring exercise options through meetup.com groups and the hospital's lifestyle center, emphasizing that consistent effort can reduce biological age by 3-5 years regardless of chronological age.
Royalmount is not just "doing fine" it is accelerating. In this episode Axel Monsaingeon sits down with Michael Stroll, Partner at Carbonleo and SVP Leasing, to break down what actually drives a successful mixed use destination in Montreal. They explore how consumer habits are changed, why occupancy momentum matters more than first month headlines, and how the right tenant mix, events, and access strategy can reposition an asset quickly. You will hear the measurable results behind the Royalmount lease up, the expansion logic for phase two retail, why a hotel on site makes sense, and how Class A office demand is being reshaped by commute patterns and lifestyle convenience. If you work in development, leasing, investment, or brokerage, this conversation is a masterclass in building durable demand through placemaking and long term vision. Topics & Timestamps
The Champions League league phase closed out in full Matchday Mayhem, and the boys are here to break it all down. Jimmy Conrad, Charlie Davies, and Tony Meola unpack an unhinged UCL matchday 8 that concluded with a dramatic goalkeeping goal for Benfica - and of course Tony has strong opinions about it (05:54)! Marvin Dills became the latest American to make his bow in the competition (10:55). Malik Tillman stole the show with his second brace of the competition (11:54), while Folarin Balogun and Weston McKennie went head-to-head in a tense scoreless draw as Monaco and Juventus moved on (18:10). Club Brugge added insult to injury for Tim Weah and Marseille (27:21), and it was heartbreak for Sergiño Dest and Ricardo Pepi as PSV crashed out (35:15). The crew then looks ahead to the Champions League Knockout Playoffs, breaking down potential matchups for the Americans still standing (34:37), before shifting their focus to today's Europa League action (40:30). And finally, it's time for a USMNT attacking midfield check-in (47:17). With Mauricio Pochettino's depth chart taking shape, the guys dig into the club form of Gio Reyna and Brenden Aaronson, debating where each stands heading into the next international window (59:10). Call It What You Want is available for free on the Audacy app as well as Apple Podcasts, Spotify and wherever else you listen to podcasts. Follow the Call It What You Want team on X: @JimmyConrad, @CharlieDavies9, @TMeola1 Visit the betting arena on CBSSports.com for all the latest in sportsbook reviews and sportsbook promos for betting on soccer For more soccer coverage from CBS Sports, visit https://www.cbssports.com/soccer/ To hear more from the CBS Sports Podcast Network, visit https://www.cbssports.com/podcasts/ Watch UEFA Champions League, UEFA Europa League, UEFA Europa Conference League, UEFA Women's Champions League, EFL Championship, EFL League Cup, Carabao Cup, Serie A, Coppa Italia, CONCACAF Nations League, CONCACAF World Cup Qualifiers, Lamar Hunt U.S. Open Cup, NWSL, Scottish Premiership, AFC Champion League by subscribing to Paramount+ Visit the betting arena on CBS Sports.com: https://www.cbssports.com/betting/ For all the latest in sportsbook reviews: https://www.cbssports.com/betting/news/sportsbook-promos/ And sportsbook promos: https://www.cbssports.com/betting/news/sportsbook-promos/ To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
Senate does not advance a package of six FY2026 spending bills ahead of Friday's deadline to avoid a partial government shutdown, but Senators and the White House are reportedly working on a deal to pass five bills as a group and separate out Homeland Security funding and extend it for a short period to allow for more talks on how to reform ICE; President Donald Trump holds a Cabinet meeting, but does not call on Homeland Security Secretary Kristi Noem or Attorney General Pam Bondi to speak and does not take any reporters' questions; White House Border Czar Tom Homan says he has ordered federal immigration authorities to work on an eventual drawdown plan for federal law enforcement in Minnesota, operations until then will be targeted and he is “staying ‘til the problem's gone”; Suspect in the attack on Rep. Ilhan Omar (D-MN) at a town hall this week faces federal charges, as she blames President Trump's rhetoric for threats to her safety; updates from the White House Cabinet meeting on the war in Ukraine, U.S. military build up near Iran, and the Israel-Hamas ceasefire, Phase 2; President's National Security Agency Director nominee testifies before the Senate Intelligence Committee; Senate Agriculture Committee passes a bill to regulate the digital assets market; some in Europe are talking about boycotting the World Cup matches in the U.S. Learn more about your ad choices. Visit megaphone.fm/adchoices
B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.
Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comFind out how the future of AI could impact your retirement during Zach Abraham's free “New Year Reset” live webinar This Thursday January 29th 3:30pm Pacific. Register at KnowYourRiskPodcast.com.Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeThere's a lot more that needs to be done. Thank God we left the WHO, but they haven't left us, I'll explain...Episode links:I FULLY support the Trump Admin pulling out of the World Health Organization and was proud to see legislation I introduced five years ago during COVID come to fruition. The WHO covered up on behalf of the ChiComms and pushes a leftist globalist agenda. Defund Tyranny.WHO SAYS: “We never imposed lockdowns or vaccine passports.” ALSO WHO: “You must follow lockdowns and use vaccine passports.” The WHO pushed policies that controlled movement and daily life, then denied it. People are NOT buying it.Bruce Alyward, senior advisor to the Director General of the World Health Organisation, pretends to not hear the question when asked if WHO would reconsider Taiwan's membership. Interviewer asks again and he shuts down meeting."We cannot afford to trust the WHO anymore." - Dr. Wahome Ngare from Kenya exposes a World Health Organization sterilization effort disguised as a vaccination campaign.BREAKING: New Study Reveals WHY Regulators Missed the DNA Contamination in mRNA Vaccinesl The answer was hiding in plain sight—and it explains everything.The CEO of Moderna says he is deeply disappointed that the company's vaccines for children are no longer being recommended. He openly confesses that the decline in demand has hurt the vaccine business. He says Moderna no longer expects to invest in new Phase 3 vaccine studies anytime soon because it no longer has access to the U.S. market.
B shares her take on dating during the "in-between phase." That space between raising teenagers and the empty nest of kids at college. PLUS: Thinking about what YOU bring to the table and how men can be even more emotional than women. See omnystudio.com/listener for privacy information.
Skywalking Through Neverland: A Star Wars / Disney Fan Podcast
Are you wondering whether Wonder Man is worth your time? In this episode, we break down Marvel's latest Disney+ series, give you the essential background on the character, and explain what you actually need to know before diving in. From Simon Williams' comic book origins to his surprising connections with Vision, Scarlet Witch, and the Avengers, we cover the fun facts, controversies, and powers that shaped Wonder Man long before his MCU debut. We also dig into how Wonder Man fits into the MCU under the Marvel Spotlight banner—designed to be more grounded, character-driven, and accessible without deep MCU homework. Starring Yahya Abdul-Mateen II as a struggling actor hiding dangerous superpowers, and Ben Kingsley returning as Trevor Slattery, the series leans hard into Hollywood satire, mentorship, and the bizarre "Doorman Clause" that bans super-powered people from acting. Our reactions are… mixed. While the show shines as a personal story about ambition, insecurity, and creative survival—anchored by a standout performance from Ben Kingsley—it struggles with tone, realism, and the weight of its MCU identity. We talk about what works, what doesn't, and whether Wonder Man feels like a forgotten experiment or a meaningful setup for something bigger down the road. Watch the YouTube version here for the best experience. Listen to the podcast episode here: Written WONDER MAN Review Wonder Man is the 19th television series in the Marvel Cinematic Universe (including both live-action and animated projects) and arrives as part of Phase 6. The series was created by Destin Daniel Cretton (Shang-Chi and the Legend of the Ten Rings) and Andrew Guest (Hawkeye, Community, Brooklyn Nine-Nine). Yahya Abdul-Mateen II, crossing superhero franchises after playing Black Manta in DC's Aquaman films, stars as Simon Williams, a struggling actor auditioning for the lead in a remake of Wonder Man, a low-budget 1980s action film that Simon once bonded over with his father. Simon carries a dangerous secret: he has explosive superpowers that he can't fully control. Worse, he must keep those powers hidden if he wants any chance at an acting career thanks to the Doorman Clause, a rule that bars super-powered individuals from working as actors. One episode dives into the origins of this clause, and it's easily among the series' most entertaining and imaginative chapters. Ben Kingsley returns as Trevor Slattery, the infamous actor hired to portray the Mandarin in Iron Man 3. Since then, the character has appeared in the Marvel short All Hail the King and film Shang-Chi and the Legend of the Ten Rings. Here, Trevor is once again chasing relevance—and is also auditioning for a role in the Wonder Man remake. Interestingly, the series never clearly states where it fits into the MCU timeline. There are only light references—photos on walls, casual mentions of "shield throwing." Frankly, that restraint is welcome. It's firmly set in the present day on the main MCU Earth, and that's more than enough. Had this been set on another timeline or Earth, this review probably wouldn't exist. Character Over Capes At its core, this is a strong, personal story about two people supporting each other in a brutal industry. Simon approaches acting with intense seriousness—reminiscent of Dustin Hoffman's character in Tootsie—while Trevor, as a mentor figure, pushes him to loosen up and trust the words on the page. Wonder Man is far more interested in the relationship between Simon Williams and Trevor Slattery than in building a new costumed icon. Through their conversations, the series thoughtfully explores what it actually means to be an actor. Abdul-Mateen II and Kingsley make for an engaging, surprisingly balanced duo. The show wisely avoids leaning into easy odd-couple clichés, which elevates their dynamic. If you enjoyed the behind-the-scenes look at show business in The Studio or Hacks, there's a lot here to like. Wonder Man ups the stakes by adding uncontrollable superpowers into an already stressful industry where almost nothing goes your way. Tone & Reality Gaps Tonally, Wonder Man struggles. It can't always decide whether it wants to be serious and emotional or silly and farcical. It oscillates between the two. The dialogue is often grounded and well-written, but the situations frequently feel forced—bent to serve the script rather than emerging naturally from reality. Living in Los Angeles, where the series is set, makes some of these moments especially hard to ignore. Being under a tight deadline to submit an audition tape and deciding to drive from Hollywood to Malibu and back—congratulations, you've just wasted three hours. These issues extend to the on-set scenes. Having worked in the film industry, many of these moments rang false. A day player wouldn't halt production because they have extensive notes. There are numerous story hiccups where disbelief must be suspended simply to keep the plot moving. A test audience likely would have flagged many of these. Performances & Standout Moments Any time Ben Kingsley is on screen, he's impossible not to root for. Simon, by contrast, is difficult to like until the final two episodes. That's clearly intentional—he's closed off and emotionally blocked—but watching someone repeatedly sabotage themselves is frustrating, even if it's thematically justified. One unquestionable highlight is the episode centered on the Doorman Clause, "Doorman". Josh Gad's appearance, along with his reworked version of "In Summer," is delightful and injects much-needed energy and creativity into the series. Release Strategy & Final Verdict Marvel continues to undermine its TV output with its release strategy. Ironheart dropped its six episodes across two days. Echo released all five at once. Wonder Man follows suit with all eight episodes dropping in a single day. The result? These shows are consumed quickly and forgotten just as fast. By the time Daredevil Season 2 arrives in March, this will likely be one of those "Oh yeah… what happened on Wonder Man again?" series.I went in with an open mind and high expectations—this is Marvel, after all. In the end, I liked Wonder Man, but too much got in the way of loving it. SPONSORS Small World Vacations is an official sponsor of Skywalking Through Neverland. Contact them for a no obligation price quote at www.smallworldvacations.com. Tell them Skywalking Through Neverland sent you.
In this episode El Bandido continues our Deer Foundation series, part of our Whitetail Strategies series, by reviewing a new book, The Total Deer Hunter Manual by Field & Stream. This has been fun to go through as it contains 301 essential skill for any deer hunter. We'll review the skills together and see what we can learn, where we have common ground and where perhaps we may have a different… Source
Most B2B podcasts fail because they skip strategy and jump straight to recording. In this solo episode of Pipe Dream, host Jason Bradwell breaks down B2B Better's Podcast to Pipeline Framework, a six-step system designed to turn a podcast from a “nice content idea” into a revenue-generating GTM asset. Jason's core point is that marketing strategy matters more than microphones. The goal isn't to ship episodes, it's to create commercial momentum. That's why B2B Better positions itself as a podcast marketing agency, not just a production company: a podcast should drive pipeline, create revenue, and ultimately turn a profit. Anything else becomes a vanity project that dies after a handful of episodes. From there, he walks through the six phases: 1) Strategy development (the most skipped step). Instead of asking what gear to buy, brands should define what success looks like, who the audience is, and what messages matter. Jason runs strategy workshops with stakeholders across marketing, sales, product, and leadership to build a “show blueprint” that clarifies the what/why/who/how and prevents random feedback from derailing things later. 2) Funnel mapping. Most companies treat podcasts as top-of-funnel awareness only, but Jason argues podcasts can move buyers through awareness, consideration, evaluation, and conversion when you map content intentionally. He introduces B2B Better's distribution grid to align segments and content to different buyer awareness stages and distribution paths. 3) Pre-production. This is the setup work that makes recording smooth: scripting, guest booking and research, and establishing visual/audio treatments so the show feels consistent and intentional. 4) Creative treatment. Here Jason draws a key distinction: production is editing raw footage into a finished episode, while producing is editorial oversight and strategic control to ensure the episode hits the right messages. Many brands only buy production, but what they really need is a producer who can guide the conversation and keep the content aligned to the goal. 5) Integrated campaigns. Distribution and promotion shouldn't be “repurpose one episode into 100 assets.” Jason pushes back on that trend because it often creates redundant content that doesn't move the needle. Distribution has to match the objective: brand awareness might mean short clips plus paid spend; ABM might mean sales enablement and targeted account plays. 6) Reporting and optimisation. A show isn't static. Someone needs to review performance at the episode, channel, and show level with what's working, what isn't, and what market feedback is signaling and then feed that back into strategy (stay the course, pivot, or double down). If you're launching a B2B podcast or already have one that feels like it's going nowhere, Jason's framework is a practical way to treat podcasting like the GTM asset it should be, align every phase to commercial outcomes, and avoid the “six episodes then abandon it” trap. 00:00 - Introduction: From concept to commercial results 01:30 - Why B2B Better is a podcast marketing agency 03:00 - Phase 1: Strategy development and the show blueprint 06:00 - Phase 2: Funnel mapping and the distribution grid 09:00 - Phase 3: Pre-production essentials 11:00 - Phase 4: Creative treatment - producing vs production 14:00 - Phase 5: Integrated campaigns and smart distribution 17:00 - Phase 6: Reporting and optimisation 20:00 - How to get started with B2B Better Connect with Jason Bradwell on LinkedIn Check out Jason's several tools in building guest lists: HubSpot CRM Clay Apollo Explore B2B Better website and the Pipe Dream podcast
George Mekhail, Managing Director of Bitcoin for Corporations at BTC Inc, explains why Bitcoin is no longer being ignored by institutions — it's being actively challenged.In this interview from the Bitcoin MENA Conference, George breaks down why corporate Bitcoin treasury companies are being targeted, how global corporate adoption is accelerating, the role of advocacy in protecting Bitcoin companies, and whether the traditional four-year Bitcoin cycle still applies.Topics covered include: • Why institutions are pushing back against Bitcoin • Corporate Bitcoin adoption around the world • Regulatory friction in Europe vs the United States • The MSCI proposal targeting Bitcoin-heavy balance sheets • Whether Bitcoin's four-year cycle is changing
Retatrutide is being called the next big leap in medical weight loss...but does the hype actually match the human data? In this episode, we break down what retatrutide is, how it works as a triple-agonist drug, and what current human trials really show in terms of fat loss, metabolic health, and side effects. We also dive into potential benefits beyond the scale, realistic expectations compared to GLP-1 drugs, and the uncomfortable but necessary question: is retatrutide headed toward widespread misuse and abuse? This is an evidence-based, no-nonsense conversation separating clinical promise from influencer exaggeration. *** Phase 3 trials are underway but not completed, Coach Vinny misspoke in the background and said passed phase 3 instead of phase 2*** Coach VinnyEmail: vinny@balancedbodies.ioInstagram: vinnyrusso_balancedbodiesFacebook: Vinny Russo Dr. ErynEmail: dr.eryn@balancedbodies.ioInstagram: dr.eryn_balancedbodiesFacebook: Eryn Stansfield LEGION 20% OFF CODEGo to https://legionathletics.com/ and use the code RUSSO for 20% off your order!
Are you wondering whether Wonder Man is worth your time? In this episode, we break down Marvel's latest Disney+ series, give you the essential background on the character, and explain what you actually need to know before diving in. From Simon Williams' comic book origins to his surprising connections with Vision, Scarlet Witch, and the Avengers, we cover the fun facts, controversies, and powers that shaped Wonder Man long before his MCU debut. We also dig into how Wonder Man fits into the MCU under the Marvel Spotlight banner—designed to be more grounded, character-driven, and accessible without deep MCU homework. Starring Yahya Abdul-Mateen II as a struggling actor hiding dangerous superpowers, and Ben Kingsley returning as Trevor Slattery, the series leans hard into Hollywood satire, mentorship, and the bizarre "Doorman Clause" that bans super-powered people from acting. Our reactions are… mixed. While the show shines as a personal story about ambition, insecurity, and creative survival—anchored by a standout performance from Ben Kingsley—it struggles with tone, realism, and the weight of its MCU identity. We talk about what works, what doesn't, and whether Wonder Man feels like a forgotten experiment or a meaningful setup for something bigger down the road. Watch the YouTube version here for the best experience. Listen to the podcast episode here: Written WONDER MAN Review Wonder Man is the 19th television series in the Marvel Cinematic Universe (including both live-action and animated projects) and arrives as part of Phase 6. The series was created by Destin Daniel Cretton (Shang-Chi and the Legend of the Ten Rings) and Andrew Guest (Hawkeye, Community, Brooklyn Nine-Nine). Yahya Abdul-Mateen II, crossing superhero franchises after playing Black Manta in DC's Aquaman films, stars as Simon Williams, a struggling actor auditioning for the lead in a remake of Wonder Man, a low-budget 1980s action film that Simon once bonded over with his father. Simon carries a dangerous secret: he has explosive superpowers that he can't fully control. Worse, he must keep those powers hidden if he wants any chance at an acting career thanks to the Doorman Clause, a rule that bars super-powered individuals from working as actors. One episode dives into the origins of this clause, and it's easily among the series' most entertaining and imaginative chapters. Ben Kingsley returns as Trevor Slattery, the infamous actor hired to portray the Mandarin in Iron Man 3. Since then, the character has appeared in the Marvel short All Hail the King and film Shang-Chi and the Legend of the Ten Rings. Here, Trevor is once again chasing relevance—and is also auditioning for a role in the Wonder Man remake. Interestingly, the series never clearly states where it fits into the MCU timeline. There are only light references—photos on walls, casual mentions of "shield throwing." Frankly, that restraint is welcome. It's firmly set in the present day on the main MCU Earth, and that's more than enough. Had this been set on another timeline or Earth, this review probably wouldn't exist. Character Over Capes At its core, this is a strong, personal story about two people supporting each other in a brutal industry. Simon approaches acting with intense seriousness—reminiscent of Dustin Hoffman's character in Tootsie—while Trevor, as a mentor figure, pushes him to loosen up and trust the words on the page. Wonder Man is far more interested in the relationship between Simon Williams and Trevor Slattery than in building a new costumed icon. Through their conversations, the series thoughtfully explores what it actually means to be an actor. Abdul-Mateen II and Kingsley make for an engaging, surprisingly balanced duo. The show wisely avoids leaning into easy odd-couple clichés, which elevates their dynamic. If you enjoyed the behind-the-scenes look at show business in The Studio or Hacks, there's a lot here to like. Wonder Man ups the stakes by adding uncontrollable superpowers into an already stressful industry where almost nothing goes your way. Tone & Reality Gaps Tonally, Wonder Man struggles. It can't always decide whether it wants to be serious and emotional or silly and farcical. It oscillates between the two. The dialogue is often grounded and well-written, but the situations frequently feel forced—bent to serve the script rather than emerging naturally from reality. Living in Los Angeles, where the series is set, makes some of these moments especially hard to ignore. Being under a tight deadline to submit an audition tape and deciding to drive from Hollywood to Malibu and back—congratulations, you've just wasted three hours. These issues extend to the on-set scenes. Having worked in the film industry, many of these moments rang false. A day player wouldn't halt production because they have extensive notes. There are numerous story hiccups where disbelief must be suspended simply to keep the plot moving. A test audience likely would have flagged many of these. Performances & Standout Moments Any time Ben Kingsley is on screen, he's impossible not to root for. Simon, by contrast, is difficult to like until the final two episodes. That's clearly intentional—he's closed off and emotionally blocked—but watching someone repeatedly sabotage themselves is frustrating, even if it's thematically justified. One unquestionable highlight is the episode centered on the Doorman Clause, "Doorman". Josh Gad's appearance, along with his reworked version of "In Summer," is delightful and injects much-needed energy and creativity into the series. Release Strategy & Final Verdict Marvel continues to undermine its TV output with its release strategy. Ironheart dropped its six episodes across two days. Echo released all five at once. Wonder Man follows suit with all eight episodes dropping in a single day. The result? These shows are consumed quickly and forgotten just as fast. By the time Daredevil Season 2 arrives in March, this will likely be one of those "Oh yeah… what happened on Wonder Man again?" series.I went in with an open mind and high expectations—this is Marvel, after all. In the end, I liked Wonder Man, but too much got in the way of loving it. SPONSORS Small World Vacations is an official sponsor of Skywalking Through Neverland. Contact them for a no obligation price quote at www.smallworldvacations.com. Tell them Skywalking Through Neverland sent you.
From completing Phase 1 drilling at the Gowganda West Project, which builds on the company's early drill discovery, to advancing plans for a diverse and balanced commodities portfolio, iMetal Resources (TSXV: IMR | OTCQB: IMRFF | FRA: A7VA) stands out as a dynamic micro-cap with strong long-term potential.Learn more as President & CEO Saf Dhillon shares key exploration updates, explains what they mean for iMetal Resources' growing momentum, and outlines the company's strategy for future growth.Discover: https://imetalresources.ca/Watch the full YouTube interview here: https://youtu.be/qWHzboRo6JIAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia
Questcorp Mining (CSE: QQQ | OTCQB: QQCMF | FSE: D910) is signaling strong potential for long-term growth, having recently released highlights from its Phase 1 Drill and Exploration Program at the La Union Project in Sonora, Mexico. Founding Director, President, and CEO Saf Dhillon shares why this milestone sets the company apart, what the team discovered in terms of gold, silver, zinc, and lead mineralization, and why the company is optimistic about future discoveries across targets.Explore: https://questcorpmining.ca/Watch the full YouTube interview here: https://youtu.be/mdbWjhZNINAAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia
On this week’s episode, we’re continuing our Guidelines Series exploring the 2022 ESC/ERS Guidelines for the diagnosis and treatment of Pulmonary Hypertension. If you missed our first episode in the series, give it a listen to hear about the most recent recommendations regarding Pulmonary Hypertension definitions, screening, and diagnostics. Today, we’re talking about the next steps after diagnosis. Specifically, we’ll be discussing risk stratification, establishing treatment goals, and metrics for re-evaluation. We’ll additionally introduce the mainstays of pharmacologic therapy for Pulmonary Hypertension. Meet Our Co-Hosts Rupali Sood grew up in Las Vegas, Nevada and made her way over to Baltimore for medical school at Johns Hopkins. She then completed her internal medicine residency training at Massachusetts General Hospital before returning back to Johns Hopkins, where she is currently a pulmonary and critical care medicine fellow. Rupali’s interests include interstitial lung disease, particularly as related to oncologic drugs, and bedside medical education. Tom Di Vitantonio is originally from New Jersey and attended medical school at Rutgers, New Jersey Medical School in Newark. He then completed his internal medicine residency at Weill Cornell, where he also served as a chief resident. He currently is a pulmonary and critical care medicine fellow at Johns Hopkins, and he’s passionate about caring for critically ill patients, how we approach the management of pulmonary embolism, and also about medical education of trainees to help them be more confident and patient centered. Key Learning Points 1) Episode Roadmap How to set treatment goals, assess symptom burden, and risk-stratify patients with suspected/confirmed pulmonary arterial hypertension (PAH). What tools to use to re-evaluate patients on treatment Intro to major PAH medication classes and how they map to pathways. 2) Case-based diagnostic reasoning Patient: 37-year-old woman with exertional dyspnea, mild edema, abnormal echo, telangiectasias + epistaxis → raises suspicion for HHT (hereditary hemorrhagic telangiectasia) and/or early connective tissue disease. Key reasoning move: start broad (Groups 2–5) and narrow using history/exam/testing. In a young patient without obvious left heart or lung disease, think more about Group 1 PAH (idiopathic/heritable/associated). HHT teaching point: HHT can cause PH in more than one way: More common: high-output PH from AVMs (often hepatic/pulmonary) Rare (1–2% mentioned): true PAH phenotype (vascular remodeling; associated with ALK1 in some patients), behaving like Group 1 PAH. 3) Functional class assessment WHO Functional Class: Class I: no symptoms with ordinary activity, only with exertion Class II: symptoms with ordinary activity Class III: symptoms with less-than-ordinary activity (can't do usual chores/shopping without dyspnea) Class IV: symptoms at rest Practical bedside tip they give: Ask if the patient can walk at their own pace or keep up with a similar-age peer/partner. If not, think Class II (or worse). 4) Risk stratification at diagnosis: why, how, and which tools Big principle: treatment choices are driven by risk, and the goal is to move patients to low-risk quickly. ESC/ERS approach at diagnosis (as described): Use a 3-strata model predicting 1-year mortality: Low: 20% ESC/ERS risk assessment variables (10 domains discussed): Clinical progression, signs of right heart failure, syncope WHO FC Biomarkers (NT-proBNP) Exercise capacity (6MWD) Hemodynamics Imaging (echo; sometimes cardiac MRI) CPET (peak VO₂; VE/VCO₂ slope) They note: even if you don't have everything, the calculator can still be useful with ≥3 variables. REVEAL 2.0: Builds on similar core variables but adds further patient context (demographics, renal function, BP, DLCO, etc.) Case result: both tools put her in intermediate risk (ESC/ERS ~1.6; REVEAL 2.0 score 8), underscoring that mild symptoms can still equal meaningful mortality risk. 5) Treatment goals and follow-up philosophy What they explicitly prioritize: Help patients feel better, live longer, and stay out of the hospital Use risk tools to communicate prognosis and to track improvement Reassess frequently (they mention ~every 3 months early on) until low risk is achieved “Time-to-low-risk” is an important treatment goal Also emphasized: The diagnosis is psychologically heavy; patients need clear counseling, reassurance about the plan, and connection to support groups. 6) Medication classes for the treatment of PAH Nitric oxide–cGMP pathway PDE5 inhibitors: sildenafil, tadalafil Soluble guanylate cyclase stimulator: riociguat Important safety point: don't combine PDE5 inhibitors with riociguat (risk of significant hypotension/hemodynamic effects) Endothelin receptor antagonists (ERAs) “-sentan” drugs: bosentan (less used due to side effects/interactions), ambrisentan, macitentan Teratogenicity emphasized Hepatotoxicity that requires LFT monitoring Can cause fluid retention and peripheral edema Prostacyclin pathway Prostacyclin analogs/agonists: Epoprostenol (potent; short half-life; IV administration) Treprostinil (IV/SubQ/oral/inhaled options) Selexipag (oral prostacyclin receptor agonist) 7) Sotatercept (post-guidelines) They note sotatercept wasn't in 2022 ESC/ERS but is now “a game changer” in practice: Mechanism: ligand trap affecting TGF-β signaling / remodeling biology Positioned as potentially more disease-modifying than pure vasodilators Still evolving: where to place it earlier vs later in regimens is an active question in the field 8) How risk category maps to initial treatment intensity General approach they outline: High risk at diagnosis: parenteral prostacyclin (IV/SubQ) strongly favored, often aggressive early Intermediate risk: at least dual oral therapy (typically PDE5i + ERA); escalate if not achieving low risk Low risk: at least one oral agent; many still use dual oral depending on etiology/trajectory For the case: intermediate-risk → start dual oral therapy (they mention tadalafil + ambrisentan as a typical choice), reassess in ~3 months; add a third agent (e.g., selexipag/prostacyclin pathway) if not low risk. References and Further Reading Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237. Erratum in: Eur Heart J. 2023 Apr 17;44(15):1312. doi: 10.1093/eurheartj/ehad005. PMID: 36017548. Condon DF, Nickel NP, Anderson R, Mirza S, de Jesus Perez VA. The 6th World Symposium on Pulmonary Hypertension: what’s old is new. F1000Res. 2019 Jun 19;8:F1000 Faculty Rev-888. doi: 10.12688/f1000research.18811.1. PMID: 31249672; PMCID: PMC6584967. Maron BA. Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer. J Am Heart Assoc. 2023 Apr 18;12(8):e029024. doi: 10.1161/JAHA.122.029024. Epub 2023 Apr 7. PMID: 37026538; PMCID: PMC10227272. Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, McLaughlin VV, Preston IR, Souza R, Waxman AB, Grünig E, Kopeć G, Meyer G, Olsson KM, Rosenkranz S, Xu Y, Miller B, Fowler M, Butler J, Koglin J, de Oliveira Pena J, Humbert M; STELLAR Trial Investigators. Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2023 Apr 20;388(16):1478-1490. doi: 10.1056/NEJMoa2213558. Epub 2023 Mar 6. PMID: 36877098. Ruopp NF, Cockrill BA. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. JAMA. 2022 Apr 12;327(14):1379-1391. doi: 10.1001/jama.2022.4402. Erratum in: JAMA. 2022 Sep 6;328(9):892. doi: 10.1001/jama.2022.13696. PMID: 35412560.
This Biotech CEO Is Creating Advanced & Personalized Therapies To Fight Cancer.Full Name: Thomas JensenTitle: Chief Executive Officer, Allarity Therapeutics Ticker: $ALLRWebsite: https://www.allarity.com/Bio:Thomas Jensen is the Chief Executive Officer of Allarity Therapeutics (NASDAQ: ALLR), a clinical-stage biopharmaceutical company advancing personalized cancer therapies. He was appointed CEO in December 2023 after nearly a decade as Chief Technology Officer, during which he helped pioneer the company's proprietary Drug Response Predictor (DRP®) platform.With over 20 years in the biotech and precision medicine space, Thomas has led Allarity through a focused strategic transformation centered on stenoparib—a first-in-class dual PARP/tankyrase inhibitor currently in Phase 2 trials for advanced ovarian cancer. Under his leadership, Allarity has achieved FDA Fast Track designation, formed key research collaborations, and presented clinical data showing landmark median overall survival of ovarian cancer patients.Company Bio:Allarity Therapeutics (NASDAQ: ALLR) is a clinical-stage biopharma company developing personalized cancer treatments guided by its proprietary DRP® companion diagnostic platform. The company's lead asset, stenoparib, is a novel, orally available dual PARP and WNT pathway inhibitor being evaluated in Phase 2 trials for advanced ovarian cancer. With headquarters in the U.S. and a research facility in Denmark, Allarity is committed to improving patient outcomes through precision oncology. Learn more at www.allarity.com
Send us a textIn this episode of the WTR Small-Cap Spotlight, host Tim Gerdeman and healthcare analyst Robert Sassoon are joined by Dr. Jim Gilligan, President and Chief Science Officer of Entropy Neurodynamics (ASX: ENP), formerly Tryptamine Therapeutics. Dr. Gilligan explains the motivation behind the company's rebrand and its decision to prioritize three core therapeutic targets: Binge Eating Disorder, Fibromyalgia, and Irritable Bowel Syndrome/abdominal pain. Although Entropy has reported positive Phase 2a results using oral psilocybin across these indications, Dr. Gilligan outlines why the company is shifting its strategy toward developing proprietary IV‑delivered psilocin formulations combined with psychotherapy, beginning with binge eating disorder. The discussion also covers Entropy's work on real‑time EEG and brain entropy as a potential biomarker, the company's financing, regulatory roadmap, and longer‑term expansion opportunities in areas such as PTSD.
Tim Lu, CEO of Senti Bio, joins In Vivo to discuss how programmable cell therapies are solving oncology's targeting problem. Lu explains the logic-gated approach behind SENTI-202, an allogeneic CAR-NK therapy for relapsed/refractory AML that achieved 50% response rates in Phase 1 while avoiding the dose-limiting toxicities that have plagued other AML cell therapies. We cover the Phase 1 ASH 2025 data showing 39% complete remission rates (all MRD-negative) with 7.6-month median duration, the rationale for using NK cells over T cells, and why synthetic biology's three-target logic gates can distinguish cancer from healthy bone marrow cells. Lu also discusses plans for pivotal trials following RMAT designation, expansion into solid tumors, and where biotech innovation is accelerating versus where clinical translation bottlenecks remain. For biopharma professionals tracking cell therapy innovation, synthetic biology applications, and AML treatment advances.
Peachtree Corners continues to push forward on what “smart city” can really mean—and in this in-person episode of Peachtree Corners Life, host Rico Figliolini sits down with City Councilman Phil Sadd (Post 1, District 1) to unpack the biggest initiatives shaping the city right now. From public safety innovation to trails, traffic, redevelopment, and housing, Phil walks through what's happening, why it matters, and what residents can expect next.Leading the conversation is a new Drone as First Responder pilot that can launch automatically from certain 911 priority calls—arriving on scene in seconds to provide real-time awareness, improve safety, and support de-escalation before officers arrive. The episode also covers major quality-of-life and economic development efforts including Crooked Creek Trail, workforce/affordable homeownership in Mechanicsville, updates on The Forum redevelopment, the new public innovation park Curiosity Corner, and upcoming mobility projects like the Peachtree Parkway lane conversion and the Winter's Chapel corridor multi-use path open house.Key takeawaysDrone as First Responder (DFR) is launching as a pilot with Brinc (integrated with Motorola's dispatch ecosystem), and Peachtree Corners is one of five partner cities—and the only one in Georgia.Crooked Creek Trail is a major long-term project (about 1.3 miles plus spurs) with heavy environmental and safety constraints due to waterway/EPA requirements; construction is still roughly two years out.Mechanicsville workforce homeownership plan uses ARPA funds for land acquisition (about five acres) and a public-private build model with price caps and anti-flip protections to keep homes affordable long-term.The Forum redevelopment is moving toward execution: Barnes & Noble relocation enables a 125-room boutique hotel on the corner; multifamily plans are updated to below 300 units, with parking decks designed to be visually screened by buildings; target start is early 2027 (funding-dependent).Curiosity Corner is a public innovation park in Technology Park with shaded seating + connectivity, plus testing for things like Pipedream underground delivery, drone delivery, and EV programs; projected completion this spring.Traffic improvement on Peachtree Parkway: converting an existing southbound turn lane into a third straight-through lane to reduce bottlenecks; funded via SPLOST with state permission.Winter's Chapel multi-use path (Phase 2) open house: joint city involvement due to corridor “zigzag” boundaries; open house is Feb 12, 5–7.Public safety discussion focuses on improving the county partnership: Phil emphasizes better communication, better data/metrics, a potential satellite office in Peachtree Corners, and addressing staffing shortages rather than rushing toward a new department vote.
Retrouvez Rothen s'enflamme de 18h à 20h sur RMC.
PJ and I close out PHASE 1 of the MCU. And good news, we're getting back together shortly to resume operations! BUT this older one first, it sees us revisiting Joss Whedon's milestone achievement bringing together all the Marvel Heroes and adding more. #marvel #avengers #mcu #ironman #captainamerica #hulk #robertdowneyjr #chrishemsworth #markruffalo #blackwidow #scarlettjohansson #chrisevans #tomhiddleston #loki
Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you!Interested in a more traditional, text rundown? Check out the HCPFive!Top 5 Healthcare Headlines for January 18-24, 2025:1. Phase 2 Data Show NS002 Intranasal Epinephrine Acts Faster Than EpiPenInterim phase 2 data suggest NS002 intranasal epinephrine may provide more rapid systemic exposure than intramuscular autoinjectors, supporting its potential as a needle-free option for anaphylaxis management.2. AHA 2026 Heart Disease and Stroke Statistics: Progress and Pitfalls, With Latha Palaniappan, MD, MSThe AHA's 2026 Heart Disease and Stroke Statistics highlight persistent gaps in cardiovascular prevention and outcomes despite advances in treatment, with continued emphasis on heart disease and stroke as leading causes of mortality in the US.3. New CHEST Recommendations Guide Biologic Use for Severe AsthmaCHEST released updated guidance to help clinicians individualize biologic selection for severe asthma based on patient characteristics, disease phenotype, and available evidence.4. Topical Steroid Concerns in Dermatology Highlighted in Nationwide SurveyA nationwide survey underscores widespread patient and caregiver concerns about long-term topical steroid use in chronic inflammatory skin diseases and a perception that current management strategies are largely reactive rather than preventive.5. Amlitelimab Effective, Safe for Atopic Dermatitis in Patients 12 Years and OlderPhase 3 data show amlitelimab was effective and well tolerated in adolescents and adults with moderate-to-severe atopic dermatitis, supporting its role as a targeted, non–T-cell-depleting biologic option.
This week: 116 days into a ceasefire, Israel has killed at least 481 Palestinians in Gaza. Redevelopment plans for the Gaza Strip were met with skepticism by people there. Palestinians also questioned whether Israel intends to follow through with the next Phase of the US-brokered ceasefire plan in Gaza. Israel has killed more than 71,654 Palestinians in Gaza since October 7th, 2023. In this episode: Hind Khoudary, (@hindkhoudary), Al Jazeera Correspondent Nida Ibrahim, (@nida_aljazeera) Al Jazeera Correspondent Episode credits: This episode was produced by David Enders. Our sound designer is Alex Roldan. Our lead of audience development and engagement is Andrew Greiner and Munera AlDosari is our engagement producer. Alexandra Locke is The Take’s executive producer. Ney Alvarez is Al Jazeera's head of audio. Connect with us: @AJEPodcasts on X, Instagram, Facebook, and YouTube
Your daily news in under three minutes. At Al Jazeera Podcasts, we want to hear from you, our listeners. So, please head to https://www.aljazeera.com/survey and tell us your thoughts about this show and other Al Jazeera podcasts. It only takes a few minutes! Connect with us: @AJEPodcasts on Twitter, Instagram, Facebook, and YouTube
2026 is humanity's "activation phase." Dallisa Hocking explains that the warm-up is over; now, radical accountability for our vibration is essential. As AI shifts our reality, we face a collective identity crisis that demands we shed corporate masks and stop being bystanders. By mastering the core energies of approval, control, and safety, we can replace fear with curiosity and navigate deep shifts in our relationships. This is the moment to move beyond old systems and step into heart-centered resonance and true soul embodiment.And while this moment is collective, how it shows up in your life is deeply personal.
In this special episode, I'm taking you back to a conversation I recorded a few years ago with one of the astrologers I admire most, Demetra George.My fascination with the Dark Moon didn't come from astrology school. It grew slowly over time, through being around magical women, healers, and seekers who understood that the quietest phase of the lunar cycle carries extraordinary power.Everything truly crystallised when I read Demetra's book Mysteries of the Dark Moon. I became determined to speak with her, and after a little persistence and quite a few emails, she finally agreed.What followed was one of the most memorable conversations I've ever had about lunar wisdom, goddess traditions, and the ancient roots of astrology.In this episode, we explore why the Dark Moon isn't something to fear, what ancient astrologers really taught about feminine spirituality, and how this hidden phase of the Moon can be used for healing, insight, and renewal.This conversation also feels especially timely as I prepare for the release of my Dark Moon Oracle Cards, now available for pre order. In this episode, we cover:How Demetra George first became fascinated with goddess mythology and astrology.Why the Dark Moon represents withdrawal, regeneration, and the sacred pause before a new cycle.The inspiration behind Mysteries of the Dark Moon.The forgotten ancient name of the Third House as the House of the Goddess.How early astrological texts linked the Moon with women's rites, dreams, and divination.Demetra's interpretations of Medusa and Lilith and reclaiming feminine power.The symbolism of serpents, Kundalini energy, and feminine wisdom.How ancient priestesses used ritual, sexuality, and lunar timing for healing and regeneration.Why goddess traditions may not have vanished, but simply entered a hidden phase.Simple Dark Moon rituals you can try at home.Clearing your space, unplugging from stimulation, and inviting dreams and insight.How astrology can act as a form of remembrance rather than prediction.Why this episode mattersThis is a conversation about slowing down in a fast world.If you've ever felt drawn to lunar cycles, goddess wisdom, or the quieter spiritual spaces between endings and beginnings, this episode is for you.Finding Demetra George Find Demetra George at https://demetra-george.com/And her amazing book MYSTERIES OF THE DARK MOON here https://geni.us/darkmoonmysteriesExplore the Dark Moon with meIf listening to this episode sparks your curiosity, I've created a free guide to help you work with the Dark Moon in a grounded and supportive way.You can download it here: https://magic.moonology.com/get-dark-moon-guideIt'll show you how to use this powerful lunar phase for release, healing, and renewal so you can move into each New Moon cycle feeling clearer and more aligned. Join the Mainly Moonology inner circle: https://moonmessages.com/magical––Follow Yasmin on socials:✨ Facebook: https://www.facebook.com/yasminbolandmoonology ✨ Instagram: https://www.instagram.com/moonologydotcom/––Mainly Moonology is a podcast for people looking to manifest their dream life leveraging the power of the moon. Tune in each week for accessible moon teachings, weekly readings, discussions about the Law of Attraction, and everything in between! Follow us for more.
In this special episode, I'm taking you back to a conversation I recorded a few years ago with one of the astrologers I admire most, Demetra George.My fascination with the Dark Moon didn't come from astrology school. It grew slowly over time, through being around magical women, healers, and seekers who understood that the quietest phase of the lunar cycle carries extraordinary power.Everything truly crystallised when I read Demetra's book Mysteries of the Dark Moon. I became determined to speak with her, and after a little persistence and quite a few emails, she finally agreed.What followed was one of the most memorable conversations I've ever had about lunar wisdom, goddess traditions, and the ancient roots of astrology.In this episode, we explore why the Dark Moon isn't something to fear, what ancient astrologers really taught about feminine spirituality, and how this hidden phase of the Moon can be used for healing, insight, and renewal.This conversation also feels especially timely as I prepare for the release of my Dark Moon Oracle Cards, now available for pre order. In this episode, we cover:How Demetra George first became fascinated with goddess mythology and astrology.Why the Dark Moon represents withdrawal, regeneration, and the sacred pause before a new cycle.The inspiration behind Mysteries of the Dark Moon.The forgotten ancient name of the Third House as the House of the Goddess.How early astrological texts linked the Moon with women's rites, dreams, and divination.Demetra's interpretations of Medusa and Lilith and reclaiming feminine power.The symbolism of serpents, Kundalini energy, and feminine wisdom.How ancient priestesses used ritual, sexuality, and lunar timing for healing and regeneration.Why goddess traditions may not have vanished, but simply entered a hidden phase.Simple Dark Moon rituals you can try at home.Clearing your space, unplugging from stimulation, and inviting dreams and insight.How astrology can act as a form of remembrance rather than prediction.Why this episode mattersThis is a conversation about slowing down in a fast world.If you've ever felt drawn to lunar cycles, goddess wisdom, or the quieter spiritual spaces between endings and beginnings, this episode is for you.Finding Demetra George Find Demetra George at https://demetra-george.com/And her amazing book MYSTERIES OF THE DARK MOON here https://geni.us/darkmoonmysteriesExplore the Dark Moon with meIf listening to this episode sparks your curiosity, I've created a free guide to help you work with the Dark Moon in a grounded and supportive way.You can download it here: https://magic.moonology.com/get-dark-moon-guideIt'll show you how to use this powerful lunar phase for release, healing, and renewal so you can move into each New Moon cycle feeling clearer and more aligned. Join the Mainly Moonology inner circle: https://moonmessages.com/magical––Follow Yasmin on socials:✨ Facebook: https://www.facebook.com/yasminbolandmoonology ✨ Instagram: https://www.instagram.com/moonologydotcom/––Mainly Moonology is a podcast for people looking to manifest their dream life leveraging the power of the moon. Tune in each week for accessible moon teachings, weekly readings, discussions about the Law of Attraction, and everything in between! Follow us for more.
This podcast is powered by Klean Freaks University.com — where real cleaners build real empires. From mop buckets to million-dollar systems, we teach you how to clean smarter, lead stronger, and scale faster.In this final episode of the Five Phases of the Entrepreneur series, we explore Phase 5: The Visionary CEO. This is the stage where business owners move beyond day-to-day execution and begin building assets, systems, and long-term impact. We talk about shifting from operator to architect, thinking in years instead of weeks, and designing a business that aligns with your values instead of constant urgency. Phase 5 isn't about scaling for applause — it's about intention, sustainability, and leadership maturity. If you're ready to build something that lasts beyond you, this episode will help clarify what comes next.Full Show Notes check KFU Link to author page, Shannon Lee Ann Millerhttps://www.amazon.com/author/shannonleeannmiller Here is the link to apply for the scholarshiphttps://forms.gle/c122YU6oNRG7Tic19 Erica Paynter is the brains behind My Virtual Bookkeeper, a bookkeeping firm for cleaning companies, and the creator of Clean Co. Cash Flow Academy and the Clean Co. Collective. She's on a mission to help cleaning business owners make sense of their numbers without boring them to tears! Erica's all about turning messy books into profit-packed powerhouses. support@myvbk.com Support the showThanks for tuning in to Cleaning Business Life, the show where we pull back the curtain on what it really takes to start, grow, and scale a thriving cleaning business without burning out. Every episode is packed with tips, stories, and strategies you can put to work right away—because you deserve a business that works for you, not the other way around. If you enjoyed today's episode, make sure to follow the podcast so you never miss a new release. And if you got value from this conversation, share it with another cleaning business owner who could use the encouragement and practical advice. Let's stay connected! You can find me online at:
A typical vaccine stimulates a person's immune system, yet only a portion of the immune response actually targets the disease it's designed to protect against. However, a new technology may be changing that dynamic.In this episode, I sit down with Lou Reese, an entrepreneur who has led or co-founded several biotech companies and has been working on synthetic peptide-based active immunotherapy medicines. He's co-CEO of United Biomedical and co-founder of Vaxxinity, Cana Life, and Axxium.He's working on a product that could—if proven successful—transform our approach to treating and preventing Alzheimer's. He and his team also have a product that has shown preliminary promise in phase 1 trials in treating Parkinson's.In this episode, he also reveals an incredible story: He and his team previously developed a peptide-based active immunotherapy vaccine candidate for COVID-19, and they successfully completed Phase 1 and Phase 2 trials. Institutional backing, however, favored Pfizer and Moderna. In 2022, Lou Reese's team was invited to the White House “Summit on the Future of COVID‑19 Vaccines,” where they presented their candidate as an alternative to Pfizer's mRNA vaccine, which by then had been associated with serious side effects.In the end, their product was never approved, and related content on YouTube was marked as misinformation.Views expressed in this video are opinions of the host and the guest, and do not necessarily reflect the views of The Epoch Times.
On the latest episode of the Politically Speaking Hour on St. Louis on the Air, STLPR's Jason Rosenbaum talks with Missouri Sen. Ben Brown about why the state should eliminate the income tax. He also discussed Sens. Eric Schmitt and Josh Hawley's views on taking over Greenland with WashU's Steven Smith. And at the end of the show, Rosenbaum spoke with future Missouri House Speaker Alex Riley about the 2026 legislative session.
This "Listen Again" episode was one of our favorites, and it deserves a re-visit! Dr. Jenni and Kim talk to Dr. Craig Heacock, an adolescent and adult psychiatrist and addiction specialist in Colorado who hosts the psychiatric storytelling podcast “Back from the Abyss.” He is a co-therapist in the Phase 3 trial of MDMA-Assisted Psychotherapy for PTSD and has particular interest in the use of psychedelics to treat severe mood disorders and PTSD. In this conversation, we talk about psychiatric drugs and their effect on our sex drive. Dive into this fascinating conversation for the first time, or again...with Dr. Craig Heacock. Find Dr. Heacocks podcast here https://www.craigheacockmd.com/podcast-page/ Kim’s blog 31-50 - https://31to50.blogspot.com/See omnystudio.com/listener for privacy information.
Interview with Brian Miller, Director & CEO Of Astra ExplorationOur previous interview: https://www.cruxinvestor.com/posts/astra-exploration-tsxvastr-pitch-perfect-november-2025-8536Recording date: 20th January 2026Astra Exploration (TSXV:ASTR) is aggressively advancing its flagship La Manchuria precious metals project in Argentina following encouraging initial drilling results that have validated management's exploration thesis. CEO Brian Miller outlined the company's progress and 2026 strategy in a recent discussion covering exploration results, geological interpretation, and capital allocation priorities.The company's most significant achievement was securing La Manchuria in mid-2024 and completing an inaugural drill program in early 2025 that intersected exceptional near-surface grades. Miller emphasized the quality of mineralization: "The grades that we've intersected there, they're not common to get repeat grades because I'm literally talking about ounces of gold and kilograms of silver in open drill intercepts near surface. And they're not one-offs. We've repeated several of those."Critically, Phase 1 results demonstrated that the mineralized system extends well beyond previous geological interpretations. The project was thought to be faulted off at both ends along strike, but Astra has proven the system continues in both directions with new parallel zones identified. This expansion fundamentally changes the scale potential, with the deposit now opening up in multiple dimensions including at depth.Astra initiated a 10,000-meter Phase 2 drill program in October 2025, with the first half focused on extending the surface footprint through shallow drilling and the second half targeting deeper zones starting March 2026. Assays from the initial phase are currently pending and expected to provide critical information about lateral continuity and the effectiveness of geophysical targeting methodology.Rather than rushing toward formal resource estimation, management is prioritizing demonstration of scale through step-out drilling. This capital-efficient approach aims to prove system extent before the expensive, dilutive infill drilling required for resource definition. The company maintains its original thesis of multi-million-ounce potential.Argentina's unprecedented political and economic reforms have attracted major mining companies including Lundin, BHP, Kinross, and Barrick to deploy significant capital in the country, validating the jurisdiction and reducing perceived country risk. Management views 2026 as having potential to match or exceed 2025's success, with near-term valuation dependent on pending assay results that will determine how much metal the expanded system contains.View Astra Exploration's company profile: https://www.cruxinvestor.com/companies/astra-explorationSign up for Crux Investor: https://cruxinvestor.com
Send us a textIn this special Flashcast episode of the WTR Small-Cap Spotlight podcast, Tim Gerdeman sits down with WTR Healthcare analyst Robert Sassoon to discuss his Initiation of Coverage Report on Anixa Biosciences. Their conversation explores Anixa's two clinical‑stage programs—one, an innovative CAR‑T cell therapy for terminal ovarian cancer patients, and the other, a breast cancer vaccine designed for both treatment and prevention. They review Phase 1 results, upcoming 2026 milestones, and how Anixa differentiates itself through both its scientific platforms and disciplined financial management.
Every reign comes to an end. After months of speculation, Lucasfilm has announced that Kathleen Kennedy will step down as President. Kathy has been President of Lucasfilm since the Disney acquisition of the company in 2012. Despite a fandom that at many times were hostile towards her, Kathy led Lucasfilm into a bright new era of Star Wars which saw so many animated shows, comics, books, live action series, and films which has expanded the mythos and helped the Galaxy reach a plethora of new fans.In her "Exit Interview" with Deadline, Kathy discusses her storied career and discuss what has happened with many cancelled projects like Steve Soderbergh and Adam Driver's The Hunt For Ben Solo, James Mangold and Beau Willimon's Dawn of The Jedi and beyond.As Kathy returns to producing (including the upcoming The Mandalorian And Grogu, and Starfighter), we salute her incredible career and wish her all the best in her future projects.While one reign ends, another begins. Kathy steps down and (as rumored) Dave Filoni and Lynwen Brennan rise. Dave will serve as President and Chief Creative Officer and Lynwen will serve as Co-President. Everyone knows about Dave's role within Lucasfilm as apprentice to George Lucas, but Lynwen's role within Lucasfilm has been equally as impressive. Lynwen has been at Lucasfilm since 1999, beginning her tenure at Industrial Light & Magic where she become its leader in 2009. She was General Manager of Lucasfilm in 2015 and President & General Manager of Lucasfilm Business in 2024. Her leadership has been recognized with a Lifetime Achievement Award from the Visual Effects Society and the honor of Commander of the Most Excellent Order of the British Empire.With this new leadership, questions and concerns arise about what we can expect from what we've called colloquially "Phase 3" of Star Wars. Join us as we celebrate Kathy's career, toast to Dave and Lynwen's new roles, and speculate about what might be in store for Star Wars future!• • •TRIAD Of The FORCE is a STAR WARS+ podcast hosted by Gus, Nani, & Chase—Puerto Rican and queer creators sharing deep dives, and heartfelt conversations from a galaxy far, far away. Featured on the STAR WARS CELEBRATION Podcast Stage (2022 & 2023), we explore STAR WARS, fantasy, comic books, and other POP-culture media honestly. We engage in inclusive commentary across film, TV, books, comics, and beyond with humor, critical analysis, and cultural perspective (without the toxicity).Follow TRIAD Of The FORCE at:BlueSky: https://bsky.app/profile/triadoftheforce.bsky.socialInstagram: https://www.instagram.com/triadoftheforce/YouTube: https://www.youtube.com/c/TriadoftheForce/If you like us, get some merch and help the channel:TeePublic: https://www.teepublic.com/user/triad-of-the-force• • •Acknowledgement: The Intro and Outro music is the Triad of the Force Theme, composed and performed by Grushkov with full permission for use by Grushkov (https://linktr.ee/Grushkov).• • •This channel is not affiliated in any way with Lucasfilm Ltd. LLC, The Walt Disney Company, or any of their affiliates or subsidiaries.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Justin Call, MD. Dr Call is a medical oncologist and hematologist at Utah Cancer Specialists in South Jordan.Dr Call explained that he has taken a unique professional path, transitioning from practicing as a general community oncologist to becoming a full-time phase 1 principal investigator within a community practice setting. He explained that he grew up in Salt Lake City, Utah in a family of educators and accountants, though he was heavily influenced by several uncles who were physicians, including one oncologist. After completing his medical training at the University of Colorado, he chose community oncology over academia because he wanted to remain a generalist who could treat all tumor types rather than being restricted to a specific disease group. A formative rotation at Rocky Mountain Cancer Centers solidified this desire, as Dr Call noted he was impressed by the deep knowledge required to treat various cancers and the positive atmosphere of outpatient care.Dr Call emphasized that his personal life significantly influenced his career choices. His son, Trevor, was diagnosed with autism at 18 months old. This diagnosis eventually led the family to move from a rural practice in Petoskey, Michigan, back to Utah to access better support services and be closer to family. His son's experience also inspired Call's wife to earn a master's degree in special education.Upon returning to Utah Cancer Specialists, Dr Call initially participated in phase 3 trials. However, he retained an interest in early-phase research from his fellowship days. In 2016, he began building a boutique phase 1 program, initially starting with just 2 hours of dedicated time per week. In 2020, his practice partnered with START (South Texas Accelerated Research Therapeutics) to launch a dedicated, full-time, community-based phase 1 program. Dr Call noted that this model is rare because phase 1 trials are highly competitive and require specialized infrastructure, such as dedicated pharmacists, coordinators, and equipment for processing pharmacokinetic samples.
Divorce doesn't come with a single moment of grief.It arrives in waves, quietly, loudly, and often long after the paperwork is signed.In this deeply validating episode of The Crazy Ex-Wives Club, Erica is joined by therapist and author Oona Metz, whose new book Unhitched: The Essential Divorce Guide for Women reframes divorce not as failure, but as a profound emotional restructuring.Together, they unpack why divorce grief is often misunderstood, why women feel “crazy” for still hurting months or years later, and why traditional grief models fall short when applied to divorce.Oona introduces her five-phase model of divorce grief, heartbreak, the emotional rollercoaster, mending, letting go, and moving on. A framework built from decades of clinical work with women navigating divorce. This conversation normalizes the emotional chaos, identity loss, and nervous system overwhelm so many women experience, while offering a grounded roadmap forward.This episode is not about rushing healing. It's about understanding it, honoring it, and trusting that rebuilding happens one stabilizing step at a time.You'll learn:Why divorce grief is different from bereavement griefWhy healing after divorce is never linearThe five phases of divorce grief and what each one actually feels likeWhy hope keeps women stuck longer than they expectHow emotional rollercoasters are a normal part of divorce recoveryWhy legal processes intensify emotional dysregulationWhat “mending” really means after emotional depletionHow self-love restores nervous system safetyWhy letting go includes releasing identity, myths, and future fantasiesHow to rebuild traditions without forcing old onesWhy moving on doesn't mean forgetting, it means re-investing energyHow community accelerates healing when friends and family can't relateWe talk about:00:00 Why divorce grief shows up in unexpected ways03:00 Why Oona wrote Unhitched after 30 years of clinical work06:00 Why women feel isolated even though divorce is common09:00 Why traditional grief models don't fully apply to divorce12:00 Phase one, heartbreak and the loss of hope15:00 Why women hold on longer than they want to18:00 Phase two, the emotional rollercoaster explained22:00 Why feeling “crazy” is actually a healthy response25:00 How the legal process amplifies emotional instability28:00 Phase three, mending and reclaiming emotional energy32:00 Why loving yourself changes how you parent and relate35:00 Divorce as family restructuring, not failure38:00 Phase four, letting go of identity and future myths42:00 Rebuilding traditions without self-betrayal46:00 Phase five, moving on without erasing the past49:00 Why healing happens faster in community52:00 Trusting the process when you're still in the painLinks Mentioned in the ShowLooking for support on your journey? Join THE CLUBReady to Define the New You? Create your BLUEPRINTLoved this week's guest? LEARN MOREContact Erica & The Crazy Ex-Wives Clubwww.thecrazyexwivesclub.comTag us @ Instagram | Facebook | TikTokDid you love this episode? Make sure to follow for more.
Au sommaire de Radio Foot internationale de ce mardi à 16h10 T.U. (rediffusion à 21h10 T.U.) : - Retour sur les terrains européens avec l'avant-dernière journée de la phase de ligue de la C1 ; - Le Sporting Portugal reçoit le PSG. ; - Choc au sommet entre leaders de championnats respectifs. ; CAN 2025, retour sur une finale qui a basculé dans le désordre. Retour sur les terrains européens avec l'avant-dernière journée de la phase de ligue de la C1. On se rapproche du dénouement. 9 matches ce soir. - Real Madrid vs Monaco. Le 11 de Pocognoli, en crise de résultats, affronte les Merengues dans leur antre, mais sous pression et en plein doute. Une Europe qui réussit mieux aux Blancos, 7ès du classement, et qui vont chercher à conforter leur position de qualifié direct pour la suite. Le Sporting Portugal reçoit le PSG. Les hommes de Luis Enrique ont l'occasion de faire un grand pas vers les 8ès de finale, face à l'ancien club de Nuno Mendes, et avant d'accueillir Newcastle. Les Leõs (14ès), avec leur public, espèrent bien finir fort. Choc au sommet entre leaders de championnats respectifs. Inter Milan/Arsenal, les Nerazzurri restent pourtant sur 2 défaites. Les Gunners s'étaient inclinés à Giuseppe Meazza la saison passée, mais n'ont pas perdu en Premier League depuis début décembre. L'expérience des Milanais va-t-elle compter dans ce duel direct entre prétendants au titre ? CAN 2025, retour sur une finale qui a basculé dans le désordre. Arbitrage contesté, sanctions jugées illégales, rôle délétère des réseaux sociaux qui attisent colère et soupçon, une victoire par chaos ? Malgré le sacre sénégalais, les interrogations subsistent sur l'équité sportive, et sur la crédibilité de l'instance dirigeante ? « La meilleure CAN de l'histoire » tranche avec les polémiques qui ont jalonné son déroulement. Comment restaurer confiance et apaisement ? Le Mondial (de Trump) peut-il échapper aux turbulences ? Autour d'Annie Gasnier : Nabil Djellit, David Lortholary et Éric Rabesandratana. Technique/réalisation : Laurent Salerno. - David Fintzel/Pierre Guérin.
"It's not really true that if you just fix your gut, you're fixing everything." If you have eczema, psoriasis, rosacea, or hives and nothing seems to work... if you've tried every elimination diet and "heal your gut" protocol only to see your skin get WORSE... if you've bounced from functional doctor to functional doctor without answers... this episode changes everything.Dr. Terri sits down with Jennifer Fugo, a clinical nutritionist who specializes exclusively in chronic skin conditions (and host of the Healthy Skin Show podcast with nearly 400 episodes), for one of the most eye-opening and controversial conversations about skin health you'll ever hear. This isn't your typical "just heal your gut" advice - it's the truth about why that approach FAILS for most people with skin issues and what actually works. WHAT YOU'LL DISCOVER: → Why "heal your gut" advice is incomplete and does a MASSIVE disservice to skin patients → The shocking truth: elimination diets can cause IgE anaphylactic food allergies in adults → Why you're bouncing from practitioner to practitioner and getting worse, not better → The Phase 2 liver detox pathway that 99% of practitioners overlook→ How milk thistle and dandelion root could be making your skin WORSE (ragweed allergens) → The cross-reactive allergen problem that practitioners don't check for → Why food is just a Band-Aid (not the root cause) for most skin conditions This isn't about ONE thing fixing everything. It's about finding YOUR root cause combo. ---TIMESTAMPS: 0:00 - Intro 1:30 - Jennifer's eczema story (and why it sparked her mission) 4:20 - Why skin issues are different than "hidden" conditions 6:15 - The "heal your gut" myth that's failing patients 7:45 - Why people bounce between practitioners getting worse 10:30 - It's not ONE thing - it's multiple root causes 12:15 - The Phase 2 liver detox pathway everyone overlooks 14:40 - Why milk thistle might be making you worse 17:20 - The glycine secret for liver support 20:15 - Cross-reactive allergens practitioners don't check 25:30 - Rosacea and stomach acid connection 30:55 - Demodex mites and rosacea (what to ask your doctor) 33:10 - How to advocate for yourself in limited appointment times 37:00 - The elimination diet danger (developing anaphylactic allergies) 41:30 - Food is a Band-Aid, not the cure ---RESOURCES MENTIONED:• The Healthy Skin Show Podcast https://www.skinterrupt.com/listen/ • Jennifer Fugo's Practice https://www.skinterrupt.com/book-a-session/ • Evexias Health Solutions (Episode Sponsor) Website: https://www.evexias.com Find a provider near you ---SUBSCRIBE for more episodes challenging conventional health wisdom and exploring what ACTUALLY works.If this episode gave you answers you've been searching for, LIKE and SHARE it with someone struggling with chronic skin conditions.COMMENT below: Have you been told to "just heal your gut" for your skin? What happened? ---ABOUT THE DR. TERRI SHOW:Dr. Terri brings you honest conversations about health, wellness, personal transformation, and the topics that matter most in today's world. From integrative medicine to nutrition to policy reform, we explore it all with expert guests who are making a real difference.New episodes weekly. Subscribe and turn on notifications so you never miss an episode. ---The Dr. Terri Show is presented by Evexias Health Solutions. For more, visit: https://www.evexias.com Connect more with Dr. Terri:
Opportunities exist in the tech sell-off, says Lisa Martin, making the case that fundamentals remain strong. Even after sentiment soured, Lisa explains that the big picture for tech doesn't change even as leaders like Nvidia (NVDA) face U.S. regulation pressures. As for software, she believes some companies need to prove a path to stronger profits, but sees cybersecurity firms like Palo Alto Networks (PANW) and CrowdStrike (CRWD) as beneficiaries.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about
Au sommaire de Radio Foot internationale de ce mardi à 16h10 T.U. (rediffusion à 21h10 T.U.) : - Retour sur les terrains européens avec l'avant-dernière journée de la phase de ligue de la C1 ; - Le Sporting Portugal reçoit le PSG. ; - Choc au sommet entre leaders de championnats respectifs. ; CAN 2025, retour sur une finale qui a basculé dans le désordre. Retour sur les terrains européens avec l'avant-dernière journée de la phase de ligue de la C1. On se rapproche du dénouement. 9 matches ce soir. - Real Madrid vs Monaco. Le 11 de Pocognoli, en crise de résultats, affronte les Merengues dans leur antre, mais sous pression et en plein doute. Une Europe qui réussit mieux aux Blancos, 7ès du classement, et qui vont chercher à conforter leur position de qualifié direct pour la suite. Le Sporting Portugal reçoit le PSG. Les hommes de Luis Enrique ont l'occasion de faire un grand pas vers les 8ès de finale, face à l'ancien club de Nuno Mendes, et avant d'accueillir Newcastle. Les Leõs (14ès), avec leur public, espèrent bien finir fort. Choc au sommet entre leaders de championnats respectifs. Inter Milan/Arsenal, les Nerazzurri restent pourtant sur 2 défaites. Les Gunners s'étaient inclinés à Giuseppe Meazza la saison passée, mais n'ont pas perdu en Premier League depuis début décembre. L'expérience des Milanais va-t-elle compter dans ce duel direct entre prétendants au titre ? CAN 2025, retour sur une finale qui a basculé dans le désordre. Arbitrage contesté, sanctions jugées illégales, rôle délétère des réseaux sociaux qui attisent colère et soupçon, une victoire par chaos ? Malgré le sacre sénégalais, les interrogations subsistent sur l'équité sportive, et sur la crédibilité de l'instance dirigeante ? « La meilleure CAN de l'histoire » tranche avec les polémiques qui ont jalonné son déroulement. Comment restaurer confiance et apaisement ? Le Mondial (de Trump) peut-il échapper aux turbulences ? Autour d'Annie Gasnier : Nabil Djellit, David Lortholary et Éric Rabesandratana. Technique/réalisation : Laurent Salerno. - David Fintzel/Pierre Guérin.
Send us a textDr. Michael Koren joins Kevin Geddings to explain what "Phase 1" means in the context of clinical research. The doctor talks about how phase 1 is the first time a new investigational treatment is used in a person, but that there is an enormous amount of work that happens before a medication gets to that point. He also discusses the other phases of research, concerns about safety, and why clinical research is so important.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!
What if the biggest metabolism disruptor today is not carbs or calories, but the toxic load you cannot see? In this episode of the Metabolic Freedom Podcast, Ben Azadi sits down with Mara Labs co-founders David Roberts and Dr. John Gildea for a deep dive into microplastics, detox pathways, and the science of sulforaphane. They break down how microplastics and the chemicals that leach from plastics can interfere with cellular function, including lysosomes, autophagy, inflammation, and hormone signaling. You will learn why sulforaphane is known for activating Nrf2, what that means for detox and repair genes, and why the conversation around metabolic health is also a conversation about toxin exposure. They also discuss berberine as a tool for metabolic flexibility, blood sugar support, ketosis, and even sleep, plus new product innovations like BarkElite for dogs. If you want practical strategies backed by research and real-world testing, this one is packed. Key Topics Covered Why microplastics are everywhere and why that matters for metabolism and longevity How microplastics may interfere with lysosomes, autophagy, and cellular cleanup What sulforaphane is and how it activates the Nrf2 pathway Phase 1, 2, and 3 detox explained in plain English Why inflammation is often the real root issue behind stubborn fat loss Berberine, AMPK, GLP-1 signaling, and metabolic flexibility Why late-night eating can wreck sleep and HRV The dog angle: joint support, inflammation, and BarkElite Coupon and Discount Browse all products featured in this episode : http://www.benazadi.com/mara Mara Labs discount code: FREEDOM 25% off from January 19, 2026 through January 26, 2026 After January 26, 2026: code still works for 15% off Follow Ben Azadi
We love to hear from our listeners. Send us a message. The Business of Biotech was back in San Francisco for the J.P. Morgan Healthcare Conference (January 12 - 15) and this week we sit down with Marc Salzberg, M.D., CEO, CMO, and Board Chair at Airway Therapeutics, a company developing a recombinant version of human surfactant protein D for several respiratory, inflammatory, and infectious diseases including bronchopulmonary dysplasia (BPD), which is currently in Phase 2b/3 trials. Brian talks about why he selected BPD as a lead clinical indication (a disease primarily affecting preterm infants), what he learned through founding and selling a CRO, how a private biotech funds a pivotal trial across continents, and offers an industry outlook for 2026. Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Trump re-ignites his tariff war with Europe in bid to acquire Greenland. Roland in Brussels joins Tony with analysis, and how Europe plans to fight Trump. Iranian analyst Hooshang tells Tony how regime change in Iran might work. Margot in Israel tells Tony why Netanyahu is against Phase 2 of Trump's peace plan.
In this episode, Cat and Nat explore the complexities of relationships, particularly focusing on the challenges of maintaining intimacy amidst the chaos of parenting. They candidly discuss how their attention is often diverted to their children, leaving little room for romantic connections. Despite this, both express a sense of stability in their marriages, acknowledging that while date nights may not be a priority, their relationships remain strong. The conversation shifts to the importance of human connection, illustrated through a story about a young woman rowing solo across the Atlantic, highlighting the balance between independence and the need for companionship.As the discussion progresses, Cat and Nat delve into the darker side of relationships, touching on the psychology of individuals who commit heinous acts, such as murder. They reflect on how seemingly normal people can harbor dark secrets, emphasizing the importance of understanding the underlying factors that contribute to such behaviors. The episode wraps up with a humorous take on dining experiences, particularly the frustrations of expensive meals and the desire for free bread, showcasing their relatable and light-hearted approach to serious topics. Hosted on Acast. See acast.com/privacy for more information.
Why does the narcissist start telling your story before you even realize the relationship is over? In this episode, self-aware narcissist Lee Hammock pulls back the curtain on the most devastating phase of the discard: The Smear Campaign.A smear campaign isn't just "gossip"—it is a coordinated, three-phase attack designed to isolate you, discredit your truth, and protect the narcissist's public image at all costs.In this episode, we explore:Phase 1: The Pre-emptive Strike – How they start "planting seeds" of doubt with your friends and family months before the breakup actually happens.Phase 2: The Flying Monkey Recruitment – Why your "loyal" friends suddenly start acting like spies and messengers for the narcissist.Phase 3: The Narrative Swap – How they take their own abusive behaviors and "project" them onto you, making you look like the unstable one.Survival Strategy: Why the urge to "clear your name" is actually a trap, and how to use silence to regain your power.You cannot win a war of words with someone who is willing to lie. You win by surviving the storm.Connect with Lee:My Courses: https://courses.mentalhealness.net 1-on-1 Coaching Calls: https://link.me/mentalhealnessAll My Link: https://beacons.page/mentalhealness Follow on Instagram/TikTok: @mentalhealnesss
© 2020-2026 Ivy Podcast Discovery LLC
